CHEK2 and thyroid gland carcinoma: Six of our BC patients carrying a CHEK2 pathogenic mutation were also diagnosed with thyroid carcinoma, acute myeloid leukemia, colon cancer, malignant melanoma, or uterine endometrial carcinoma.